CHARLES RIVER LABS INTL (NYSE: CRL)

View Portfolio
Back to Investopedia
Back to Investopedia




$36.41 0.72 (2.02%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
40.14
52-Week Low Price
23.03
Avg Volume (3 Mo.)
0.00 M
Market Cap
2.35 B
P/E Ratio (TTM)
11.0
Diluted EPS (TTM)
2.32
Shares
65.90 M
Dividend Rate ($) / (%)
0.00/0.00
100%
0%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 36% - CRL has outperformed the S&P 500 by 10%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
KING PHARMACEUTICALS INC (KG) $11.41 -  $0.11(0.97%)2.82 B
VALEANT PHARMACEUTICALS (VRX) $35.55 -  $1.06(3.07%)2.80 B
TALECRIS BIOTHERAPEUTI... (TLCR) $22.48 -  $0.07(0.31%)2.76 B
NBTY INC (NTY) $42.36 -  $0.71(1.65%)2.74 B
AMYLIN PHARMACEUTICALS (AMLN) $17.49 -  $0.16(0.89%)2.43 B
ENDO PHARMACEUTICALS HLD (ENDP) $19.49 -  $0.04(0.20%)2.30 B
TECHNE CORP (TECH) $61.19 -  $0.00(0.00%)2.29 B
BIOVAIL CORP (BVF) $14.00 -  $0.26(1.89%)2.21 B
MYRIAD GENETICS INC (MYGN) $21.38 -  $0.29(1.34%)2.13 B
OSI PHARMACEUTICALS INC (OSIP) $34.14 -  $0.03(0.09%)2.02 B
As of February 09, 2010 at 2:41 PM ET
STOCK ANALYSIS
Stock Analysis
Contract Biotech Is Booming (MDZ, CRL, CVD)
We examine three companies that the big drug makers call on when they need a little testing done.
View All Stock Analysis
CRL RELATED HEADLINES
arrow
Charles River Laboratories (CRL) NewsBite - CRL Upgraded By Deutsche Bank
Charles River Laboratories International (CRL) was upgraded today by analysts at Deutsche Bank and the stock is now at $34.10, up $0.79 (2.36%) on volume of 662,595 shares traded. The analysts lifted CRL to Buy from Hold. Over the last 52 weeks the stock has ranged from a low of $23.03 to a high of $40.14. Charles River Laboratories International stock has been showing suppor...
At Market Intelligence Center 1/7/2010
arrow
Charles River Laboratories (CRL) NewsBite - CRL Downgraded By Barclays Capital
Charles River Laboratories International (CRL) was downgraded today by analysts at Barclays Capital and the stock is now at $33.60, down $0.79 (-2.3%) on volume of 486,514 shares traded. The analysts downgraded CRL to Equal Weight from Overweight. Over the last 52 weeks the stock has ranged from a low of $19.92 to a high of $40.14. Charles River Laboratories International stock has been s...
At Market Intelligence Center 11/9/2009
arrow
Charles River Laboratories (CRL) NewsBite - CRL Upgraded By Goldman Sachs
Charles River Laboratories International (CRL) was upgraded today by analysts at Goldman Sachs and the stock is now at $37.60, down $0.66 (-1.73%) on volume of 540,184 shares traded. The analysts upgraded CRL to Neutral from Sell. Over the last 52 weeks the stock has ranged from a low of $19.92 to a high of $41.95. Charles River Laboratories International stock has been showing s...
At Market Intelligence Center 10/20/2009
arrow
StockPreacher.com Issues Technical Trading Overview for WuXi PharmaTech (Cayman) Inc.
StockPreacher.com Issues Technical Trading Overview for WuXi PharmaTech (Cayman) Inc.
by GlobeNewswire 9/24/2009
arrow
Solid Stocks in Tough Times
<ul> <li>Apollo with 20% enrollment growth in Q209</li> <li>Rocky Brands' dramatic increase in net income</li> <li>More news from today: APEI, SHPGY, PKI, ESI, FFIV, SCSC, SIAL, TLAB, CRL, CKP, MSCC, SBH, QGEN</li> <li>See our real money trades free real-time on Twitter</li> </ul>
Wall Street Media 5/12/2009
arrow
Charles River Laboratories (CRL) NewsBite - CRL Downgraded By Jefferies & Co.
Charles River Laboratories (CRL) was downgraded today by analysts at Jefferies & Co. and the stock is now at $28.00, down $1.59 (-5.37%) on volume of 757,686 shares traded. The analysts downgraded the stock to Hold from Buy. Over the last 52 weeks the stock has ranged from a low of $19.92 to a high of $69.19. Charles River Laboratories stock has been showing support arou...
At Market Intelligence Center 4/20/2009
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2